国际肿瘤学杂志 ›› 2014, Vol. 41 ›› Issue (7): 549-553.doi: 10.3760/cma.j.issn.1673422X.2014.07.020

• 论著 • 上一篇    下一篇

人附睾分泌蛋白4与糖类抗原125对卵巢肿瘤的诊断价值

孙婷,杜丽莉,徐晓琴,王艳,韩存芝,荆结线   

  1. 030013 太原,山西省肿瘤医院病因及肿瘤标志物检测室
  • 出版日期:2014-08-04 发布日期:2014-08-04
  • 通讯作者: 荆结线,Email:byshcz@vip.163.com E-mail:byshcz@vip.163.com

The diagnostic value of human epididymis protein 4 and carbohydrate  antigen 125 for patients with ovarian neoplasms

 SUN  Ting, DU  Li-Li, XU  Xiao-Qin, WANG  Yan, HAN  Cun-Zhi, JING  Jie-Xian   

  1. The Etiology and Tumor Makers Laboratory, Shanxi Cancer Hospital, Taiyuan 030013, China
  • Online:2014-08-04 Published:2014-08-04
  • Contact: Jing Jiexian E-mail:byshcz@vip.163.com

摘要: 目的探讨人附睾分泌蛋白4(HE4)和糖类抗原125(CA125)的检测对卵巢肿瘤患者的诊断价值。方法采用酶联免疫法检测1 109例卵巢肿瘤患者的HE4和CA125的值,评估单一和联合检测的敏感性和特异性。结果①绝经后卵巢肿瘤患者HE4、CA125水平均高于未绝经卵巢肿瘤患者(t=8.40,P<0.05;t=7.02,P<0.05);卵巢肿瘤患者生育胎数越多,HE4及CA125水平越高,差异有统计学意义(F=15.36,P<0.05;F=13.00,P<0.05)。②卵巢癌患者HE4水平高于交界性及卵巢良性疾病患者,差异有统计学意义(t=13.68,P<0.05;t=14.94,P<0.05);卵巢癌患者的CA125水平高于交界性及卵巢良性疾病患者(t=14.16,P<0.05;t=17.27,P<0.05);有腹腔积液和脉栓者HE4水平明显高于无腹腔积液和脉栓者(t=7.08,P<0.05;t=4.41,P<0.05);有腹腔积液和脉栓者CA125水平明显高于无腹腔积液和脉栓者(t=9.67,P<0.05;t=4.75,P<0.05)。③术后3个月随访230例患者,其HE4、CA125水平明显低于术前,差异有统计学意义(t=9.86,P<0.05;t=5.12,P<0.05)。④HE4、CA125、卵巢恶性肿瘤风险计算法(ROMA)值的接受者操作特性曲线(ROC)下面积无明显差异。⑤CA125的敏感性高于HE4,但其特异性低于HE4,HE4+CA125联合检测敏感性高于单一检测及ROMA值,特异性低于单一检测及ROMA值。按绝经状态分组后的ROMA值具有更高的敏感性(73.84%,84.19%)和较低的特异性(66.06%,66.67%)。结论对于卵巢肿瘤患者,CA125的敏感性高,HE4的特异性高,联合检测可进一步提高诊断的敏感性及准确性。

关键词: 卵巢肿瘤, 抗原, 肿瘤相关, 碳水化合物, 人附睾蛋白4

Abstract: ObjectiveTo evaluate the diagnostic value of human epididymis protein 4(HE4) and carbohydrate antigen 125(CA125) for distinguishing between benign and malignant ovarian neoplasms. Methods1109 patients with ovarian neoplasms were enrolled in this study, serum concentration of HE4 and CA125 was assayed using ELISA technique.And the markers were evaluated for significance separately and in combination. Results1 Serum levels of HE4 and CA125 were significantly higher in postmenopausal women than those in premenopausal women(t=8.40,P<0.05;t=7.02,P<0.05). In addition, the more children the patients born, the higher serum levels of these two markers were(F=15.36,P<0.05;F=13.00,P<0.05). 2 Serum HE4 levels were significantly higher in the ovarian cancer patients compared with those seen in patients with benign or borderline tumor(t=13.68,P<0.05;t=14.94,P<0.05). Serum CA125 levels were significantly higher in the ovarian cancer patients compared with those seen in patients with benign or borderline tumor(t=14.16,P<0.05;t=17.27,P<0.05). Morever, it also appared in the ovarian cancer patients with ascites and vascular embolism. Morever,the levels of HE4 were significantly higher in the ovarian cancer with ascites and vascular embolism than without it(t=7.08,P<0.05;t=4.41,P<0.05),the levels of CA125 were significantly higher in the ovarian cancer with ascites and vascular embolism than without it(t=9.67,P<0.05;t=4.75,P<0.05). 3 During followup, serum HE4 and CA125 levels significantly decreased at 3 months after operation(t=9.86,P<0.05;t=5.12,P<0.05). 4 Receiver operating characteristic curve,ROC) analysis revealed that no difference was observed in AUC values for HE4, CA125 and risk of ovarian malignancy algorithm(ROMA). 5 Compared to CA125, HE4 had significantly higher specificity and lower sensitivity.However,sensitivity were increased when the two markers were combined with each other. However,the sensitivity of combination with two markers was higher than single detection and ROMA,but the specificity was lower in combination with two markers than single detection and ROMA.If we divide the ROMA by a woman′s menopausal status, ROMA has a higher sensitivity(73.84%,84.19%) and lower specificity(66.06%,66.67%). ConclusionsThe levels of CA125 has a high sensitivity, and the levels of HE4 is a high specificity. CA125 combined with HE4 can provide a more sensitivity and accurate predictor of ovarian cancer than either alone.

Key words: Ovarian neoplasms, Antigens, tumorassociated,carbohydrate, Human epididymis protein4